Net prices of new antiobesity medications.

Published in: Obesity (Silver Spring, Md.) (2024)

The magnitude of manufacturer discounts underscores the need to consider net price information in studies that inform private and public payers' decision-making around coverage of GLP1s for obesity.

Keyphrases

decision making
healthcare
insulin resistance
metabolic syndrome
weight loss
health insurance
type diabetes
affordable care act
weight gain
high fat diet induced
case control
health information
emergency department
body mass index
skeletal muscle
physical activity